Christopher L Corless Selected Research

O-methyl-serine dodecylamide hydrochloride

1/2022

Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher L Corless Research Topics

Disease

81	Neoplasms (Cancer) 01/2022 - 03/2002
41	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 03/2002
12	Breast Neoplasms (Breast Cancer) 10/2021 - 06/2005
11	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2005
9	Adenocarcinoma 12/2018 - 12/2004
8	Carcinoma (Carcinomatosis) 01/2016 - 07/2005
8	Melanoma (Melanoma, Malignant) 05/2015 - 09/2003
7	Disease Progression 10/2022 - 02/2005
6	Carcinogenesis 01/2022 - 07/2003
6	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2004
6	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 12/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 03/2002
3	Ductal Carcinoma 07/2013 - 01/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013 - 08/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2010 - 05/2002
3	Leukemia 05/2009 - 12/2003
3	Systemic Mastocytosis 05/2009 - 11/2006
3	Aggressive Fibromatosis (Desmoid) 05/2008 - 06/2005
2	Rhabdomyosarcoma 01/2022 - 01/2013
2	Cholangiocarcinoma 08/2015 - 10/2012
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2014 - 01/2014
2	Pathologic Complete Response 12/2011 - 05/2007
2	Fibrosis (Cirrhosis) 11/2011 - 03/2007
2	Liver Diseases (Liver Disease) 09/2010 - 04/2003
2	Papilloma (Papillomatosis) 01/2010 - 07/2005
2	Dermatofibrosarcoma 05/2008 - 02/2005
2	Mastocytosis 11/2006 - 03/2002
2	Squamous Cell Carcinoma of Head and Neck 05/2006 - 07/2004
2	Seminoma 01/2004 - 03/2002
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2003 - 03/2002
1	Bites and Stings (Sting) 10/2021
1	Triple Negative Breast Neoplasms 10/2021
1	Glioma (Gliomas) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020
1	Epilepsy (Aura) 10/2019
1	Injection Site Reaction 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Vomiting 01/2016

Drug/Important Bio-Agent (IBA)

41	Imatinib Mesylate (Gleevec)FDA Link 11/2021 - 03/2002
27	Phosphotransferases (Kinase)IBA 10/2021 - 03/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2004
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2003
9	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2002
9	ParaffinIBA 11/2016 - 07/2004
9	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2014 - 12/2003
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 05/2002
7	Monoclonal AntibodiesIBA 01/2013 - 07/2003
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
6	Biological ProductsIBA 12/2016 - 12/2004
4	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 01/2007
4	Formaldehyde (Formol)FDA Link 11/2016 - 04/2010
4	Biomarkers (Surrogate Marker)IBA 03/2015 - 05/2006
4	Sunitinib (Sutent)FDA Link 07/2012 - 01/2008
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 01/2014
3	Codon (Codons)IBA 11/2017 - 07/2004
3	Tyrosine (L-Tyrosine)FDA Link 09/2014 - 05/2008
3	Cadherins (E-Cadherin)IBA 12/2012 - 07/2005
3	AntibodiesIBA 03/2009 - 07/2003
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2005 - 03/2002
2	CollagenIBA 01/2021 - 02/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 06/2005
2	Dasatinib (BMS 354825)FDA Link 01/2016 - 05/2009
2	Gemcitabine FDA Link 08/2015 - 08/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2015 - 07/2013
2	ChromatinIBA 02/2014 - 10/2011
2	DesminIBA 01/2014 - 04/2011
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 03/2009
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2010 - 01/2004
2	Oncogene Proteins (Oncogene Protein)IBA 12/2008 - 01/2003
2	Transforming Growth Factor-beta Type II ReceptorIBA 05/2006 - 07/2005
2	Complementary DNA (cDNA)IBA 08/2005 - 07/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2005 - 07/2004
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	O-methyl-serine dodecylamide hydrochlorideIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021
1	selitrectinibIBA 10/2021
1	entrectinibIBA 10/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2016

Therapy/Procedure

42	Therapeutics 10/2022 - 03/2002
8	Drug Therapy (Chemotherapy) 10/2019 - 01/2005
4	Neoadjuvant Therapy 01/2022 - 05/2007
4	Radiotherapy 08/2015 - 07/2006
3	Semiconductors 11/2016 - 03/2013
3	Liver Transplantation 09/2010 - 05/2002
3	Transplantation 09/2010 - 05/2002
2	Immunotherapy 10/2021 - 01/2019
2	Precision Medicine 05/2017 - 01/2015
2	Lasers (Laser) 04/2010 - 10/2008
2	Chemoprevention 07/2005 - 12/2004
1	Metastasectomy 10/2022
1	Hepatectomy 01/2022
1	Castration 01/2017
1	Cystectomy 01/2016